Oruka Therapeutics, Inc.
ORKAFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Oruka Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 15 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 22, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Allworth Financial LP | 2026-03-31 | 205 | $10.1K | SEC filing |
| EntryPoint Capital, LLC | 2026-03-31 | 6,120 | $300K | SEC filing |
| J.Safra Asset Management Corp | 2026-03-31 | 472 | $23.2K | SEC filing |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 2026-03-31 | 18,229 | $894K | SEC filing |
| Bank of New York Mellon Corp | 2026-03-31 | 106,883 | $5.24M | SEC filing |
| FRANKLIN RESOURCES INC | 2026-03-31 | 1,004,056 | $49.2M | SEC filing |
| Deep Track Capital, LP | 2026-03-31 | 2,034,203 | $99.8M | SEC filing |
| NISA INVESTMENT ADVISORS, LLC | 2026-03-31 | 298 | $14.6K | SEC filing |
| SIGNATUREFD, LLC | 2026-03-31 | 23 | $1.13K | SEC filing |
| IFP Advisors, Inc | 2026-03-31 | 3 | $147 | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 910 | $44.6K | SEC filing |
| Fairmount Funds Management LLC | 2026-03-31 | 3,705,262 | $182M | SEC filing |
| ROTHSCHILD INVESTMENT LLC | 2026-03-31 | 26 | $1.28K | SEC filing |
| E Fund Management Co., Ltd. | 2026-03-31 | 5,090 | $250K | SEC filing |
| Cable Car Capital, LP | 2026-03-31 | 200,000 | $9.81M | SEC filing |
| MAI Capital Management | 2026-03-31 | 1 | $50 | SEC filing |
| MERCER GLOBAL ADVISORS INC /ADV | 2026-03-31 | 802,470 | $39.4M | SEC filing |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2026-03-31 | 20,964 | $1.02M | SEC filing |
| Virtus Investment Advisers, LLC | 2026-03-31 | 9,034 | $443K | SEC filing |
| Palo Alto Investors LP | 2026-03-31 | 59,985 | $2.94M | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Oruka Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2018-02-26 · VENROCK HEALTHCARE CAPITAL PARTNERS LP: Larger than all 70 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-22 | Agarwal Arjun · Senior Vice President, Finance | Common Stock | S — Open market or private sale | −888 | 80.01 | SEC filing |
| 2026-06-22 | Agarwal Arjun · Senior Vice President, Finance | Common Stock | S — Open market or private sale | −699 | 82.15 | SEC filing |
| 2026-06-15 | Goncalves Joana · Chief Medical Officer | Common Stock | S — Open market or private sale | −5,064 | 69.42 | SEC filing |
| 2026-06-15 | Goncalves Joana · Chief Medical Officer | Common Stock | S — Open market or private sale | −947 | 69.69 | SEC filing |
| 2026-06-15 | Goncalves Joana · Chief Medical Officer | Common Stock | S — Open market or private sale | −1,636 | 68.38 | SEC filing |
| 2026-06-15 | Goncalves Joana · Chief Medical Officer | Common Stock | S — Open market or private sale | −300 | 70.62 | SEC filing |
| 2026-06-15 | Sandler Laura Lee · Chief Operating Officer | Common Stock | S — Open market or private sale | −600 | 69.69 | SEC filing |
| 2026-06-15 | Klein Lawrence Otto · Chief Executive Officer | Common Stock | S — Open market or private sale | −1,729 | 69.69 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-15 | Goncalves Joana · Chief Medical Officer | Common Stock | M — Exercise or conversion of derivative security | +3,500 | SEC filing |
| 2026-06-15 | Goncalves Joana · Chief Medical Officer | Common Stock | M — Exercise or conversion of derivative security | +3,500 | SEC filing |
| 2026-06-15 | Goncalves Joana · Chief Medical Officer | Employee Stock Option (right to buy) | M — Exercise or conversion of derivative security | −3,500 | SEC filing |
| 2026-06-15 | Goncalves Joana · Chief Medical Officer | Employee Warrant (right to buy) | M — Exercise or conversion of derivative security | −3,500 | SEC filing |
| 2026-06-12 | Agarwal Arjun · Senior Vice President, Finance | Common Stock | M — Exercise or conversion of derivative security | +1,459 | SEC filing |
| 2026-06-12 | Agarwal Arjun · Senior Vice President, Finance | Employee Stock Option (right to buy) | M — Exercise or conversion of derivative security | −8,000 | SEC filing |
| 2026-06-12 | Agarwal Arjun · Senior Vice President, Finance | Employee Stock Option (right to buy) | M — Exercise or conversion of derivative security | −1,459 | SEC filing |
| 2026-06-12 | Agarwal Arjun · Senior Vice President, Finance | Common Stock | M — Exercise or conversion of derivative security | +8,000 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-01-23 | Dambkowski Carl · Director | Common Stock | J — Other acquisition or disposition | +116,483 | SEC filing |
| 2024-08-29 | Ma-Weaver Jacob · Other | Stock option (right to buy) | J — Other acquisition or disposition | −6,000 | SEC filing |
| 2024-08-29 | Ma-Weaver Jacob · Other | Stock option (right to buy) | J — Other acquisition or disposition | −12,000 | SEC filing |
| 2022-12-16 | Ma-Weaver Jacob · Director, 10% owner, other | Put Option | E — Expiration of short derivative position | −300 | SEC filing |
| 2022-07-01 | Funicular Funds, LP · 10% owner, other | Put Option | J — Other acquisition or disposition | +14,500 | SEC filing |
| 2022-07-01 | Funicular Funds, LP · 10% owner, other | Put Option | J — Other acquisition or disposition | −14,500 | SEC filing |
| 2022-07-01 | Funicular Funds, LP · 10% owner, other | Common Stock | J — Other acquisition or disposition | +2,580,452 | SEC filing |
| 2022-07-01 | Funicular Funds, LP · 10% owner, other | Common Stock | J — Other acquisition or disposition | −2,580,452 | SEC filing |
Showing 8 of 8 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.